• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia.

作者信息

Mosekilde L, Christensen M S, Lund B, Sorensen O H, Melsen F

出版信息

Acta Endocrinol (Copenh). 1977 Mar;84(3):559-65. doi: 10.1530/acta.0.0840559.

DOI:10.1530/acta.0.0840559
PMID:576530
Abstract

Serum 25-hydroxycholecalciferol (25-HCC) and serum parathyroid hormone (iPTH) were measured in 59 randomly selected adult epileptic outpatients receiving chronic anticonvulsant therapy. Quantitative morphometric analysis of iliac crest biopsies was performed. A mild degree of osteomalacia was found which was inversely correlated to dietary vitamin D intake. Serum 25-HCC was reduced in the epileptic patients compared to a control group, although dietary intake of vitamin D was higher than the mean daily intake in the Danish population. Serum 25-HCC was positively correlated to dietary vitamin D intake, but not correlated to the severity of bone changes, indicating that other factors than circulating 25-HCC are responsible for the development of anticonvulsant osteomalacia. Serum 25-HCG was inversely correlated to serum iPTH in patients with a low dietary calcium intake. The mean value of serum iPTH was not increased, and there was no correlation between serum iPTH and bone morphometry.

摘要

相似文献

1
The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia.
Acta Endocrinol (Copenh). 1977 Mar;84(3):559-65. doi: 10.1530/acta.0.0840559.
2
Interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and morphometric bone changes in anticonvulsant osteomalacia. Therapeutic effect of vitamin D2.
Calcif Tissue Res. 1977 May;22 Suppl:473-8. doi: 10.1007/BF02064135.
3
Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia.
Acta Med Scand. 1977;201(4):303-7. doi: 10.1111/j.0954-6820.1977.tb15704.x.
4
Development of anticonvulsant osteomalacia in epileptic patients on phenytoin treatment.
Acta Neurol Scand. 1974;50(4):527-32. doi: 10.1111/j.1600-0404.1974.tb02798.x.
5
[Diagnosis of anticonvulsant osteomalacia in adults (author's transl)].
Dtsch Med Wochenschr. 1977 Dec 23;102(51):1872-7. doi: 10.1055/s-0028-1105588.
6
Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy. Short-term effect of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol.
Acta Med Scand. 1979;205(5):405-9. doi: 10.1111/j.0954-6820.1979.tb06073.x.
7
Anticonvulsant osteomalacia determined by quantitative analysis of bone changes. Population study and possible risk factors.通过骨变化定量分析确定的抗惊厥药所致骨软化症。人群研究及可能的危险因素。
Acta Med Scand. 1976;199(5):349-55. doi: 10.1111/j.0954-6820.1976.tb06747.x.
8
Effect of phenytoin on bone and vitamin D metabolism.苯妥英对骨骼和维生素D代谢的影响。
Ann Neurol. 1979 Apr;5(4):374-8. doi: 10.1002/ana.410050411.
9
Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs.服用抗惊厥药物的癫痫患者中25-羟胆钙化醇的血浆水平及治疗效果
Br Med J. 1972 Oct 7;4(5831):9-12. doi: 10.1136/bmj.4.5831.9.
10
Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children.智障儿童抗惊厥药物治疗相关的骨软化症
Pediatrics. 1975 Jul;56(1):45-50.

引用本文的文献

1
Global Disruption of α2A Adrenoceptor Barely Affects Bone Tissue but Minimizes the Detrimental Effects of Thyrotoxicosis on Cortical Bone.α2A肾上腺素能受体的整体破坏对骨组织影响甚微,但能最大程度减轻甲状腺毒症对皮质骨的有害影响。
Front Endocrinol (Lausanne). 2018 Aug 28;9:486. doi: 10.3389/fendo.2018.00486. eCollection 2018.
2
Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs.
Eur J Pediatr. 1982 Sep;139(1):52-5. doi: 10.1007/BF00442080.
3
On the pathogenesis of anticonvulsant-drug-induced alterations of calcium metabolism.抗惊厥药物引起钙代谢改变的发病机制
Eur J Pediatr. 1982 May;138(3):202-5. doi: 10.1007/BF00441202.
4
Sequential changes in mineral metabolism and serum vitamin D metabolite concentrations produced by phenobarbital administration in the rat.苯巴比妥给药对大鼠矿物质代谢及血清维生素D代谢物浓度的系列影响
Calcif Tissue Int. 1983 May;35(3):376-82. doi: 10.1007/BF02405062.
5
Drugs and vitamin deficiency.药物与维生素缺乏症。
Drugs. 1979 Oct;18(4):278-98. doi: 10.2165/00003495-197918040-00002.
6
Phenobarbital-induced alterations in the metabolism of [3H]vitamin D3 by the perfused rachitic rat liver in vitro.苯巴比妥对体外灌注的佝偻病大鼠肝脏中[3H]维生素D3代谢的影响。
J Clin Invest. 1979 Oct;64(4):1112-7. doi: 10.1172/JCI109550.
7
Anticonvulsant drug-induced osteomalacia: alterations in mineral metabolism and response to vitamin D3 administration.
Calcif Tissue Int. 1979 Mar 13;27(1):13-8. doi: 10.1007/BF02441155.